Enkeleida Nikaï
Enkeleida Nikaï publishes mostly in Rheumatology, Immunology and Dermatology, on topics such as Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies and Systemic Lupus Erythematosus Research.
- World rank
- #1,717,936 of 7,710,434 ranked researchers
- Rank in Belgium
- #15,742 of 67,186
- Works
- 28
- Citations
- 636
- Citations per work
- 22.7
What does Enkeleida Nikaï research?
Enkeleida Nikaï's work is mostly in Medicine (54%), Immunology and Microbiology (14%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1553.9%
- Medicine1553.9%
- Everything else725.6%
- Life Sciences414.1%
- Social Sciences26.4%
- 1Rheumatology32% of their works
- 2Immunology14% of their works
- 3Dermatology9% of their works
- 4Hematology9% of their works
- 5Economics and Econometrics6% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Dermatology and Skin Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Hematopoietic Stem Cell Transplantation
- Autoimmune and Inflammatory Disorders Research
Which keywords describe Enkeleida Nikaï's research?
The keywords of their largest research topics: Autoantibodies, IL-17, TH17 Cells, Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Antiphospholipid Syndrome and Spondyloarthritis.
- Hemophagocytic Lymphohistiocytosis
- Bone Marrow Niche
- Cost-effectiveness Analysis
- Filaggrin
- Spondyloarthritis
- Ankylosing Spondylitis
- Inflammation
- IL-17
- Autoantibodies
- TH17 Cells
- Rheumatoid Arthritis
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Skin Microbiome
- Quality of Life
- Hematopoietic Stem Cells
- Juvenile Idiopathic Arthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Autoantibodies172 topics
- IL-17101 topic
- TH17 Cells101 topic
- Inflammation91 topic
- Rheumatoid Arthritis91 topic
- Ankylosing Spondylitis81 topic
- Antiphospholipid Syndrome81 topic
- Spondyloarthritis81 topic
- Systemic Lupus Erythematosus81 topic
- Filaggrin71 topic
- Skin Microbiome71 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Bone Marrow Niche31 topic
- Hematopoietic Stem Cells31 topic
- Hemophagocytic Lymphohistiocytosis31 topic
- Juvenile Idiopathic Arthritis31 topic
Where does Enkeleida Nikaï work?
Enkeleida Nikaï's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Enkeleida Nikaï have?
OpenAlex counts 28 works and 636 citations for Enkeleida Nikaï, an h-index of 11, ranking #1,717,936 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Enkeleida Nikaï. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.